Eisai Co. has entered into a joint research agreement with four research organizations (KAN Research Institute, National Center for Global...
Read morePOINT Biopharma (POINT) announced plans today to establish its first U.S. manufacturing facility in Indianapolis. “Indiana has established itself as...
Read moreBristol Myers Squibb announced the presentation of data across its portfolio, aimed at addressing solid tumor and hematologic malignancies in...
Read moreArcturus Therapeutics Holdings Inc., a leading clinical-stage messenger RNA (mRNA) medicines and vaccines company, and Catalent, Inc., the leading global...
Read moreAGC Biologics , a leading provider of biopharmaceutical contract development and manufacturing organization (CDMO), announced its partnership with AdaptVac. The...
Read moreCytovance Biologics, a contract development and manufacturing organization (CDMO) and a subsidiary of the Shenzhen Hepalink Pharmaceutical Group Co., Ltd.,...
Read moreMateon Therapeutics, Inc dedicated to development OT-101, a TGF-β antisense drug candidate, announced that Mateon has delivered the requisite testing...
Read moreAgilent Technologies Inc. (NYSE: A) introduced three new microarrays to meet the needs of cytogenetic laboratories conducting both prenatal and...
Read moreIktos, a French artificial intelligence (AI) start-up company, has joined forces with California-based research institute SRI International to accelerate discovery...
Read moreApplied BioMath , the industry-leader in applying systems pharmacology and mechanistic modeling, simulation, and analysis to de-risk drug research and...
Read morePharma Advancement is a leading Pharma information centric website. On one side Pharmaadvancement.com has established itself as one of the most efficient and comprehensive source of Pharma information online, dedicated to providing decision makers in all the Pharma industry sectors with reliable, accurate and useful insights into happenings in the Pharma sector.
© 2017 Copyright © Valuemediaservices 2017 All rights reserved.